‘Is This Going to Become Another Pandemic?’: What We Heard This Week

: They scour the most important new findings across the journals, curating and distilling the new information for the benefit of our readers. Our writers also attend roughly 75 medical conferences a year in the U.S. and abroad to bring you the most relevant meeting coverage across all the major specialties. “,”affiliation”:””,”credential”:””,”url_identifier”:”mt9773″,”avatar_url”:””,”avatar_alt_text”:”MedPage Today Staff”,”twitter”:””,”links”:{“signal”:””,”bluesky”:””,”website”:””,”linkedin”:””,”muckrack”:””},”has_author_page”:1,”byline”:null,”full_name”:”MedPage Today Staff”,”title”:””,”url”:”https:\/\/www.medpagetoday.com\/people\/mt9773\/medpage-today staff”,”bluesky”:””}]”/>

“Is this going to become another pandemic? No. Are we learning a lot? Yes.” — Carlos del Rio, MD, of Emory University in Atlanta, addressing concerns over the recent cruise ship-related hantavirus outbreak.

“Can this data be believed?” — Philip Rosenfeld, MD, PhD, of the University of Miami Bascom Palmer Eye Institute, discussing new data about the efficacy of geographic atrophy treatments.

“If our scientific foundation erodes, we are in deep trouble.” — Arjun Manrai, PhD, of Harvard Medical School in Boston, on the rise of artificial intelligence-fabricated citations in medical literature.

“The war on reproductive healthcare is falling to women.” — Julia Mendiola, MD, of the Allegheny Health Network Women’s Institute in Pittsburgh, highlighting the surge in female — but not male — sterilization procedures post-Dobbs.

“Across 17 patient safety metrics, we see sustained unmistakable improvement nationally.” — Leah Binder, president and CEO of the Leapfrog Group, which reported that 372 of 450 hospitals earned “straight As” for safety.

“We need to be forever vigilant that patients might be purchasing mislabeled substances.” — Noah Berland, MD, of NYC Health + Hospitals in Brooklyn, New York, discussing a case of a young woman admitted to the cardiac ICU after consuming multiple doses of a dietary supplement.

“This potentially makes dosing of a GLP-1 agonist more complicated.” — Christopher Romero, MD, of the Icahn School of Medicine at Mount Sinai in New York City, noting the complexities of prescribing GLP-1 receptor agonists to pediatric patients with type 1 diabetes and obesity.

“Uterus transplantation is rapidly moving from an experimental procedure to a real clinical option.” — Liza Johannesson, MD, PhD, of Baylor University Medical Center in Dallas, on the evolution of uterus transplants as a viable solution for women with absolute uterine infertility.

Please enable JavaScript to view the comments powered by Disqus.